v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenue        
Product revenues, net $ 18,634 $ 18,085 $ 38,667 $ 35,489
License revenues and royalties 614 754 1,432 6,383
Total revenue, net 19,248 18,839 40,099 41,872
Operating expense        
Cost of product sales (2,349) (836) (5,964) (2,897)
Research and development (17,366) (30,090) (37,243) (59,018)
Selling and marketing (12,572) (10,147) (25,280) (20,700)
General and administrative (9,701) (8,822) (19,597) (18,777)
Restructuring and impairment expenses (2,674) (13,091) (2,674) (13,091)
Total operating expense (44,662) (62,986) (90,758) (114,483)
Loss from operations (25,414) (44,147) (50,659) (72,611)
Other income (expense)        
Interest income 1,819 1,934 3,813 3,988
Interest expense (13,508) (12,997) (25,857) (25,227)
Other, net 20,538 (182) 23,170 21
Total other income (expense), net 8,849 (11,245) 1,126 (21,218)
Loss before income taxes (16,565) (55,392) (49,533) (93,829)
Income tax expense 0 (1,254) 0 (1,419)
Net loss $ (16,565) $ (56,646) $ (49,533) $ (95,248)
Net loss per share        
Net loss per share, basic (in dollars per share) $ (0.11) $ (0.50) $ (0.32) $ (0.86)
Net loss per share, diluted (in dollars per share) $ (0.11) $ (0.50) $ (0.32) $ (0.86)
Weighted average shares outstanding, basic (in shares) 155,016,023 113,743,358 154,581,598 110,490,935
Weighted average shares outstanding, diluted (in shares) 155,016,023 113,743,358 154,581,598 110,490,935